New vaccine combo shows promise in advanced skin cancer trial
Disease control
Ongoing
This study tests two experimental cancer vaccines, SCIB1 and iSCIB1+, when added to standard immunotherapy drugs (nivolumab with ipilimumab or pembrolizumab) for people with advanced melanoma that cannot be removed by surgery. The goal is to see if the vaccines are safe and can i…
Phase: PHASE2 • Sponsor: Scancell Ltd • Aim: Disease control
Last updated May 17, 2026 06:59 UTC